Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing kidney tubulointerstitial damage during a period of time
go back to main search page
Accession:CMO:0003649 term browser browse the term
Definition:A measurement in which the number of individuals in a study population that develop kidney tubulointerstitial damage within a determined period of time, are compared to the total number of individuals in the study population. Usually expressed as a percentage, but could be expressed as a ratio.
Synonyms:exact_synonym: kidney tubulointerstitial damage incidence;   percentage of study population developing renal tubulointerstitial damage during a period of time;   renal tubulointerstitial damage incidence



show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "percentage of study population developing kidney tubulointerstitial damage during a period of time" (CMO:0003649)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        organ non-tumorous lesion incidence/prevalence measurement 4
          kidney non-tumorous lesion incidence/prevalence measurement 0
            kidney tubulointerstitial damage incidence/prevalence measurement 0
              percentage of study population developing kidney tubulointerstitial damage during a period of time 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ non-tumorous lesion measurement 28
          organ non-tumorous lesion incidence/prevalence measurement 4
            kidney non-tumorous lesion incidence/prevalence measurement 0
              kidney tubulointerstitial damage incidence/prevalence measurement 0
                percentage of study population developing kidney tubulointerstitial damage during a period of time 0
paths to the root